245 related articles for article (PubMed ID: 20408767)
1. Pharmacotherapy of neuroblastoma.
George RE; Diller L; Bernstein ML
Expert Opin Pharmacother; 2010 Jun; 11(9):1467-78. PubMed ID: 20408767
[TBL] [Abstract][Full Text] [Related]
2. The Challenge of Developing New Therapies for Childhood Cancers.
Balis FM
Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
[TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
4. Neuroblastoma: Therapeutic strategies for a clinical enigma.
Modak S; Cheung NK
Cancer Treat Rev; 2010 Jun; 36(4):307-17. PubMed ID: 20227189
[TBL] [Abstract][Full Text] [Related]
5. New therapeutic targets for the treatment of high-risk neuroblastoma.
Wagner LM; Danks MK
J Cell Biochem; 2009 May; 107(1):46-57. PubMed ID: 19277986
[TBL] [Abstract][Full Text] [Related]
6. Targeted therapy of hepatocellular cancer.
Wysocki PJ
Expert Opin Investig Drugs; 2010 Feb; 19(2):265-74. PubMed ID: 20074016
[TBL] [Abstract][Full Text] [Related]
7. Neuroblastoma: biology, prognosis, and treatment.
Park JR; Eggert A; Caron H
Pediatr Clin North Am; 2008 Feb; 55(1):97-120, x. PubMed ID: 18242317
[TBL] [Abstract][Full Text] [Related]
8. [Prognosis of neuroblastoma in childhood. Methods of assessment and clinical use].
Pérel Y; Valteau-Couanet D; Michon J; Lavrand F; Coze C; Bergeron C; Notz A; Plantaz D; Chastagner P; Bernard F; Thomas C; Rubie H
Arch Pediatr; 2004 Jul; 11(7):834-42. PubMed ID: 15234382
[TBL] [Abstract][Full Text] [Related]
9. Disialoganglioside directed immunotherapy of neuroblastoma.
Modak S; Cheung NK
Cancer Invest; 2007 Feb; 25(1):67-77. PubMed ID: 17364560
[TBL] [Abstract][Full Text] [Related]
10. Targeting programmed cell death pathways with experimental therapeutics: opportunities in high-risk neuroblastoma.
Goldsmith KC; Hogarty MD
Cancer Lett; 2005 Oct; 228(1-2):133-41. PubMed ID: 15927359
[TBL] [Abstract][Full Text] [Related]
11. System-level analysis of neuroblastoma tumor-initiating cells implicates AURKB as a novel drug target for neuroblastoma.
Morozova O; Vojvodic M; Grinshtein N; Hansford LM; Blakely KM; Maslova A; Hirst M; Cezard T; Morin RD; Moore R; Smith KM; Miller F; Taylor P; Thiessen N; Varhol R; Zhao Y; Jones S; Moffat J; Kislinger T; Moran MF; Kaplan DR; Marra MA
Clin Cancer Res; 2010 Sep; 16(18):4572-82. PubMed ID: 20651058
[TBL] [Abstract][Full Text] [Related]
12. [Immunotherapy of poor-prognosis neuroblastoma in children: from bench to bedside].
Rousseau R; Combaret V; Yvon E; Schell M; Philip I; Puisieux A; Frappaz D; Philip T; Bergeron C
Bull Cancer; 2006 Feb; 93(2):153-61. PubMed ID: 16517413
[TBL] [Abstract][Full Text] [Related]
13. [Management strategy in neuroblastoma].
Balwierz W
Przegl Lek; 2004; 61 Suppl 2():3-8. PubMed ID: 15686038
[TBL] [Abstract][Full Text] [Related]
14. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
Schmidt ML; Lal A; Seeger RC; Maris JM; Shimada H; O'Leary M; Gerbing RB; Matthay KK
J Clin Oncol; 2005 Sep; 23(27):6474-80. PubMed ID: 16116154
[TBL] [Abstract][Full Text] [Related]
15. Beyond sorafenib: novel targeted therapies for advanced hepatocellular carcinoma.
Zhu AX
Expert Opin Investig Drugs; 2010 May; 19(5):663-72. PubMed ID: 20367287
[TBL] [Abstract][Full Text] [Related]
16. Novel inhibitors in development for hepatocellular carcinoma.
Wörns MA; Galle PR
Expert Opin Investig Drugs; 2010 May; 19(5):615-29. PubMed ID: 20374038
[TBL] [Abstract][Full Text] [Related]
17. Combined use of chemotherapy and 131I-metaiodobenzylguanidine in the treatment of advanced-stage neuroblastoma.
Sari O; Uğur O; Emir S; Akyüz C
Turk J Pediatr; 2001; 43(1):29-33. PubMed ID: 11297155
[TBL] [Abstract][Full Text] [Related]
18. Evolving concepts in the systemic drug therapy of breast cancer.
Norton L
Semin Oncol; 1997 Aug; 24(4 Suppl 10):S10-3-S10-10. PubMed ID: 9275000
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in neuroblastoma.
Bowen KA; Chung DH
Curr Opin Pediatr; 2009 Jun; 21(3):350-6. PubMed ID: 19381091
[TBL] [Abstract][Full Text] [Related]
20. Three decades of chemotherapy for childhood cancer: from cure 'at any cost' to cure 'at least cost'.
Craft AW; Pearson AD
Cancer Surv; 1989; 8(3):605-29. PubMed ID: 2561755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
